Does RUXOLITINIB Cause Squamous cell carcinoma? 413 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 413 reports of Squamous cell carcinoma have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.6% of all adverse event reports for RUXOLITINIB.
413
Reports of Squamous cell carcinoma with RUXOLITINIB
0.6%
of all RUXOLITINIB reports
26
Deaths
75
Hospitalizations
How Dangerous Is Squamous cell carcinoma From RUXOLITINIB?
Of the 413 reports, 26 (6.3%) resulted in death, 75 (18.2%) required hospitalization, and 10 (2.4%) were considered life-threatening.
Is Squamous cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 413 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Squamous cell carcinoma?
ADALIMUMAB (456)
TACROLIMUS (327)
INFLIXIMAB (313)
RITUXIMAB (313)
LENALIDOMIDE (304)
PREDNISONE (267)
RANITIDINE (260)
CYCLOSPORINE (254)
METHOTREXATE (252)
USTEKINUMAB (246)
Which RUXOLITINIB Alternatives Have Lower Squamous cell carcinoma Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE